19.06.2007 18:46:00
|
Charles River Laboratories' CEO James C. Foster Named An Ernst & Young Entrepreneur Of The Year(R) Award Recipient
James C. Foster, Chairman, President and Chief Executive Officer of
Charles River Laboratories International, Inc. (NYSE: CRL), was named
one of the New England region’s 2007
Entrepreneurs of the Year by Ernst & Young LLP at an awards ceremony
held in Boston last week. Mr. Foster was awarded the honor in the
Biotechnology category, joining 14 other regional business leaders who
were chosen for their exceptional leadership within their industry
sector.
"For 21 years, Ernst & Young has recognized
outstanding entrepreneurship through our Entrepreneur Of The Year®
program,” said Bryan Pearce, Ernst & Young
Entrepreneur Of The Year®
program director for New England. "This year’s
award recipients are truly an inspiration to all. We salute them for
their drive, determination and hard work –
and congratulate them on their success.”
Mr. Foster was nominated by Ty Howe of Marsh USA, who wrote in his
nomination: "Jim Foster views the world with
a critical eye towards what he could do better, faster, more effectively
to succeed not just tomorrow, but twenty years from now…
A time always comes when a business arrives at the edge; Jim prefers to
lead the charge rather than find himself there unexpectedly.”
Jim Foster said, "I am so honored to be
included among a group of truly talented individuals who are recognized
as among the best in their field. I share this award with the terrific
team at Charles River Laboratories; each colleague here is the real
engine behind the successful execution of our shared vision to
effectively serve our customers.”
All award recipients were selected by an independent panel of judges
composed of past Ernst & Young Entrepreneur Of The Year®
alumni. New England award recipients are eligible for consideration for
the Ernst & Young Entrepreneur Of The Year®
2007 national program. Award recipients in several categories, as well
as the overall national Ernst & Young Entrepreneur Of The Year®
award recipient, will be announced at the annual awards gala in Palm
Springs, California, on November 17, 2007. The overall national
Entrepreneur Of The Year®
award recipient is then considered for the worldwide event held in Monte
Carlo.
The Ernst & Young Entrepreneur Of The Year®
awards program celebrates its 21st anniversary
this year and continues to recognize the leaders and visionaries who are
creating and building world-class businesses. Awards are given to
entrepreneurs who have demonstrated excellence and extraordinary success
in such areas as innovation, financial performance, and personal
commitment to their businesses and communities.
About the Ernst & Young Entrepreneur
Of The Year Awards
The Entrepreneur Of The Year®
awards program was created and is produced by professional services firm
Ernst & Young LLP. As the first award of its kind, the Ernst & Young
Entrepreneur Of The Year®
Award recognizes outstanding entrepreneurs who are building and leading
dynamic and growing businesses. The program, which celebrated its 20th
anniversary in 2006, honors entrepreneurs through regional, national and
global award programs in over 125 cities and 40 countries.
About Charles River Laboratories
Charles River Laboratories based in Wilmington, Massachusetts, partners
with global pharmaceutical and biotechnology companies, government
agencies and leading academic institutions to advance the drug discovery
and development process, bringing drugs to market faster and more
efficiently. Charles River's 8,000 employees serve clients worldwide.
For more information on Charles River, visit our website at www.criver.com.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Charles River Laboratories International Inc.mehr Nachrichten
20.01.25 |
S&P 500-Wert Charles River Laboratories International-Aktie: So viel Verlust hätte eine Charles River Laboratories International-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
16.01.25 |
Angespannte Stimmung in New York: S&P 500 beendet die Donnerstagssitzung im Minus (finanzen.at) | |
16.01.25 |
Angespannte Stimmung in New York: S&P 500 verbucht nachmittags Verluste (finanzen.at) | |
16.01.25 |
NYSE-Handel: S&P 500 mittags mit Gewinnen (finanzen.at) | |
16.01.25 |
Minuszeichen in New York: S&P 500 zum Start des Donnerstagshandels im Minus (finanzen.at) | |
15.01.25 |
Börse New York: S&P 500 beendet den Mittwochshandel im Plus (finanzen.at) | |
14.01.25 |
NYSE-Handel: S&P 500 notiert zum Handelsende im Plus (finanzen.at) | |
14.01.25 |
Dienstagshandel in New York: S&P 500 am Dienstagnachmittag in der Gewinnzone (finanzen.at) |
Analysen zu Charles River Laboratories International Inc.mehr Analysen
Aktien in diesem Artikel
Charles River Laboratories International Inc. | 157,45 | -0,94% |